DaVita Acquires MedSleuth

January 18, 2022

DaVita Inc. acquired transplant software company MedSleuth to deepen its transplant-care capabilities and improve connectivity among transplant candidates, centers, physicians and care teams. MedSleuth will operate as a wholly-owned subsidiary and its flagship products (BREEZE and MATCHGRID) will support DaVita's efforts to expand transplant access and streamline the transplant process.

Buyers
DaVita Inc.
Targets
MedSleuth
Location
California, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.